AZD1386
AZD1386 is a pharmaceutical drug with 11 clinical trials. Historical success rate of 72.7%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
4
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
72.7%
8 of 11 finished
27.3%
3 ended early
0
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Esophageal Hypersensitivity Study in Patients With Gastroesophageal Reflux Disease (GERD)
Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1386
Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Osteoarthritis (OA) of the Knee
Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1386
Formulation and Food Effect Study of AZD1386 in Healthy Volunteers
Clinical Trials (11)
Esophageal Hypersensitivity Study in Patients With Gastroesophageal Reflux Disease (GERD)
Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1386
Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Osteoarthritis (OA) of the Knee
Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1386
Formulation and Food Effect Study of AZD1386 in Healthy Volunteers
Double-blind Placebo-controlled 2-part Study Assessing the Safety, Tolerability and PK of AZD1386 in Healthy Volunteers
Study to Evaluate Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Peripheral Neuropathic Pain
AZD1386 Japanese Multiple Ascending Dosing Study
Esophageal Hypersensitivity Study in Healthy Volunteers
Investigation of Rate+Extent of Excretion of Radioactivity in Urine+Faeces After Oral Administration of [14C]AZD1386
Study to Investigate the Effects Single Oral Dose of AZD1386 (Capsaicin)
All 11 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 11